ArticleMicrosystems & nanoengineering2026
Skin-like micropumps transform human motion into fluidic flow via morphing valves.
Article in Microsystems & nanoengineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Soft, skin-conformal fluidic systems are essential for wearable healthcare; however, micropumps that rely on rigid external hardware for actuation have limited portability and on-body integration. Here, we introduce OSMiPump, a power-free, strain-driven micropump that directly converts natural human motion into unidirectional fluid transport using a soft, monolithic architecture. OSMiPump integrates out-of-surface microchannels (OSMiCs) with self-actuated valves (OSMiValves), where cyclic tensile strain induces volume reduction and valve snap-through/snap-back, producing reliable directionality over repeated strain cycles. Computational fluid-structure interaction modeling and nonlinear shell deformation analysis validate the operating mechanism. Experimentally, OSMiPump exhibits predictable performance across valve geometries, strain levels and profiles, fluid viscosities, and inlet/outlet resistance configurations. At 20% strain, it achieves average flow rates up to ~0.16 µL/s under low-resistance conditions and maintains ~0.02 µL/s under high-resistance conditions, reaching peak pressures of ~11 kPa and sustaining an average pressure of ~0.6 kPa, with consistent operation over 100 cycles. The self-morphing architecture further enables tunable pumping behavior, including adjustable strain thresholds and response dynamics. Wearable demonstrations show direct actuation by body motion and enable both on-body delivery and removal for applications such as wound care and drug administration during physical rehabilitation, exercise, or daily activities. Integration into silicone socks and skin-mounted Tegaderm films illustrates the versatility of the platform. Together, these results establish OSMiPump as a soft, monolithic, and skin-conformal micropump for next-generation wearable biomedical systems.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.